首页> 外国专利> Pharmaceutical formulation of sodium salt of telmisartan

Pharmaceutical formulation of sodium salt of telmisartan

机译:替米沙坦钠盐的药物制剂

摘要

Formulaci n medicamentosa de la sal s dica cristalina del 4 - 2-n-propil-4-metil-6- (1-metil-bencimidazol-2-il) -bencimidazol-1-ilmetil -bifenil-2-carbox lico (telmisart Requirement 1: pharmaceutical composition, which is characterized by the presence of tellurium salt and a heliostat. 13. Claim 4: the composition of claims 1 to 3, which are characterized by the presence of endosulfan hydrochloride (HCTZ). Claim 12: the composition of claim 1, which is characterized by the compressed mass of a dry particle of the active substance classified as sodium telluride, containing Manitoba, magnesium stearate, hydroxypropyl cellulose and other related substances, as well as a mixture of chlorosulfuryl hydrazide and Manitoba,Microcrystalline cellulose and glycerin starch. Claim 13: the composition of claim 1 or claim 3, which is characterized by the presence of other pharmaceutical active substances together with tellurium salts.
机译:药物配方-2-n-propil-4-metil-6-(1-met-bencimidazol-2-il)-bencimidazol-1-ilmetil -bifenil-2-carbox lico(telmisart要求1:药物组合物,其特征在于存在碲盐和定日镜13.权利要求4:权利要求1至3的组合物,其特征在于存在硫丹盐酸盐(HCTZ)。权利要求12:所述组合物2.根据权利要求1所述的方法,其特征在于,包含马尼托巴,硬脂酸镁,羟丙基纤维素和其他相关物质以及氯磺酰肼和马尼托巴的混合物的,分类为碲化钠的活性物质的干燥颗粒的压缩质量,微晶纤维素权利要求13:权利要求1或权利要求3的组合物,其特征在于存在其他药物活性物质以及碲盐。

著录项

  • 公开/公告号AR087210A2

    专利类型

  • 公开/公告日2014-02-26

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH;

    申请/专利号AR2012P102583

  • 发明设计人 KOHLRAUSCH ANJA;

    申请日2012-07-17

  • 分类号A61K31/4184;A61K9/20;A61K31/39;A61K31/41;A61K31/549;A61P7/10;A61P9/04;A61P9/10;A61P9/12;

  • 国家 AR

  • 入库时间 2022-08-21 15:58:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号